Metagenomi (Series B)
Funding Details
Awarder
Inbox
Date Award
January 27, 2022
Vertical
Gene Editing
Funding URL
View Funding Page
Funding Amount
$175,000,000
Company Info
Founders
Brian C. Thomas
Market
Therapeutics
Location
Emeryville, California, USA
Coinvestors
Deep Track Capital, Eventide Asset Management, Farallon Capital Management, Frazier Healthcare Partners, Humboldt Fund, Marshall Wace, Millennium Management, PFM Health Sciences, Pura Vida Investments, RA Capital Management, Surveyor Capital
Company Description

Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms.

Links
Website
Back to HomeBack to Gene Editing DealsView Funding Announcement